Aflibercept in lung cancer

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.13, Iss.1, 2013-01, pp. : 115-120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

World Conference on Lung Cancer

By Felip Enriqueta Rosell Rafael

Expert Opinion on Biological Therapy, Vol. 3, Iss. 8, 2003-12 ,pp. : 1295-1298

Informa Healthcare

Access to resources Recommend Favorite

A herbal medicine for the treatment of lung cancer

By Ranga Rama Sowmyalakshmi Srinivasan Burikhanov Ravshan Akbarsha Mohammed Chendil Damodaran

Molecular and Cellular Biochemistry, Vol. 280, Iss. 1-2, 2005-12 ,pp. : 125-133

Springer Publishing Company

Access to resources Recommend Favorite

Molecular genetic markers in diagnosis of lung cancer

By Ponomaryova A. Rykova E. Cherdyntseva N. Choinzonov E. Laktionov P. Vlassov V.

Molecular Biology, Vol. 45, Iss. 2, 2011-04 ,pp. : 175-189

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

p53 mutations, benzo[a]pyrene and lung cancer

By Krawczak Michael Cooper David N.

Mutagenesis, Vol. 13, Iss. 4, 1998-07 ,pp. : 319-320

Oxford University Press

Access to resources Recommend Favorite

Immune alterations and emerging immunotherapeutic approaches in lung cancer

By Dasanu Constantin A Sethi Nishant Ahmed Nausheen

Expert Opinion on Biological Therapy, Vol. 12, Iss. 7, 2012-07 ,pp. : 923-937

Informa Healthcare

Access to resources Recommend Favorite